Insmed said on Wednesday it had discontinued the development of its experimental anti-inflammatory drug to treat a chronic sinus condition after it failed to show benefit in a mid-stage study, sending ...
The Well News on MSN
FDA approves add-on treatment for severe asthma
WASHINGTON - The Food and Drug Administration has approved Exdensur as an add-on maintenance treatment for patients aged 12 ...
The ReBoost Nasal Spray may contain mold and microbial contamination, while the ClearLife Allergy Nasal Spray may be linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback